ambrisentan 5 MG Oral Tablet

1 INDICATIONS AND USAGE Ambrisentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): • To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II-III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%). Ambrisentan tablets are an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1): To improve exercise ability and delay clinical worsening. Studies establishing effectiveness included trials predominantly in patients with WHO Functional Class II-III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%) ( 1 ).

Mylan Pharmaceuticals Inc.

FDA Reported Adverse Reactions
`[1] dyspnoea` `[2] fatigue` `[3] headache` `[4] nausea` `[5] diarrhoea` `[6] pneumonia` `[7] drug ineffective` `[8] death` `[9] off label use` `[10] pain`

4 years ago

ROUND PINK M AN

16 HOW SUPPLIED/STORAGE AND HANDLING

AMBRISENtan Tablets are available containing 5 mg or 10 mg of

AMBRISENtan. The 5 mg tablets are pink, film-coated, round, unscored tablets debossed with M on one side of the tablet and AN on the other side. They are available as follows: NDC 0378-4270-93 bottles of 30 tablets The 10 mg tablets are pink, film-coated, capsule shaped, unscored tablets debossed with M on one side of the tablet and AN1 on the other side. They are available as follows: NDC 0378-4271-93 bottles of 30 tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Store

AMBRISENtan tablets in their original packaging. Dispense only in original container. PHARMACIST: Dispense a Medication Guide with each prescription.

More pills like ROUND M AN

Related Pills

ambrisentan 10 MG Oral Tablet

Mylan Pharmaceuticals Inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site